8-K: zSpace Inc. to Delist from Nasdaq, Deregister Common Stock

zSpace, Inc. announced its intention to voluntarily delist its common stock from The Nasdaq Stock Market and deregister it with the SEC, citing costs and limited benefits amid a trading suspension.

Summary

• zSpace, Inc. is voluntarily delisting its common stock from The Nasdaq Capital Market and will deregister it under the Securities Exchange Act of 1934.
• The company has notified Nasdaq of its intention and plans to file a Form 25 with the SEC around September 25, 2026.
• Trading of zSpace's common stock has been suspended on Nasdaq since April 28, 2026, following a delisting determination that was upheld on appeal.
• The decision to voluntarily delist was made by the board of directors to provide certainty regarding the delisting and deregistration process.
• Key factors influencing the decision include the suspension of trading, the substantial costs of maintaining listing and SEC compliance, limited benefits of continued listing, and the demands on management resources.
• The delisting is expected to become effective around October 5, 2026, with the deregistration of the common stock under Section 12(b) effective around December 24, 2026.
• Following these steps, zSpace intends to file a Form 15 in early January 2027 to suspend its remaining SEC reporting obligations.
• The company's common stock is currently quoted on the OTC market under the symbol ZSPC and is expected to continue to be quoted there.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative development, indicating a company moving away from major exchange listing due to past issues and likely facing significant financial or operational challenges.

Positives

• The voluntary delisting provides certainty regarding the timing of the delisting and deregistration process.
• The company aims to reduce substantial direct and indirect costs associated with maintaining its Nasdaq listing and SEC reporting requirements.
• Management resources can be redirected from compliance demands to other company priorities.
• The common stock is expected to continue to be quoted on the OTC market (ZSPC).

Negatives

• The company's common stock has been suspended from trading on Nasdaq since April 28, 2026.
• Nasdaq previously determined to delist the common stock, and the company's appeal was denied.
• The limited benefits of continued listing are acknowledged due to the trading suspension.
• There is no assurance that any broker-dealer will continue to make a market in or quote the company's common stock on the OTC market.

Risks

• The timing of regulatory processes (Form 25 filing, SEC effectiveness) could impact the delisting timeline.
• Actions of third parties, including Nasdaq and the SEC, could affect the process.
• There is uncertainty regarding the continued quotation of the common stock on the OTC market and whether broker-dealers will maintain a market.
• The company's ability to meet future reporting obligations under the Exchange Act will be suspended after filing Form 15, potentially impacting information availability for investors.

Future Outlook

The company expects the delisting to become effective around October 5, 2026, and the deregistration of its common stock under Section 12(b) to become effective around December 24, 2026. Subsequently, in early January 2027, the company intends to file a Form 15 to suspend its remaining reporting obligations under the Exchange Act.

Management Comments

• The Company's board of directors determined to proceed with a voluntary filing in order to provide certainty as to the timing of the delisting and deregistration process.
• The board considered factors including the suspension of trading, substantial costs of maintaining registration and SEC compliance, limited benefits of continued registration, and demands on management resources.

Industry Context

StockSavvy.ai notes that delisting from a major exchange like Nasdaq and deregistering with the SEC is typically a sign of significant financial distress or a strategic shift away from public market scrutiny, often seen in companies facing severe operational challenges or seeking to drastically cut costs. This move by zSpace, following a trading suspension and denied appeal, aligns with a pattern of companies exiting public markets when facing insurmountable listing requirements or unsustainable compliance burdens.

Stakeholder Impact

• Shareholders: Reduced liquidity and potential difficulty in trading shares, increased uncertainty about the company's future and valuation. Continued quotation on OTC may offer some trading, but with less transparency and potentially wider bid-ask spreads.
• Creditors: May face increased risk due to reduced transparency and potential financial instability implied by delisting.
• Employees: Potential impact on morale and job security if the delisting is a precursor to further financial difficulties or restructuring.
• Customers: May perceive the company as less stable, potentially impacting purchasing decisions, though the core business operations are not directly addressed in this filing.

Next Steps

• File a Form 25 with the SEC on or about September 25, 2026.
• Delisting from Nasdaq expected to become effective on or about October 5, 2026.
• Deregistration of common stock under Section 12(b) expected to become effective on or about December 24, 2026.
• File a Form 15 with the SEC in early January 2027 to suspend remaining reporting obligations.

Key Dates

Recommendation

The voluntary delisting from Nasdaq, following a trading suspension and denied appeal, coupled with the intent to deregister and suspend SEC reporting obligations, strongly indicates severe underlying financial or operational issues. This move significantly reduces transparency and liquidity for shareholders, making it a high-risk situation. The company's future on the OTC market is also uncertain regarding market-making support. Therefore, a sell recommendation is warranted.

Keywords

delisting, deregistration, Nasdaq, SEC reporting, OTC market, Form 25, Form 15, stock trading